CN103495232A - Intelligent drug release device - Google Patents
Intelligent drug release device Download PDFInfo
- Publication number
- CN103495232A CN103495232A CN201310483151.2A CN201310483151A CN103495232A CN 103495232 A CN103495232 A CN 103495232A CN 201310483151 A CN201310483151 A CN 201310483151A CN 103495232 A CN103495232 A CN 103495232A
- Authority
- CN
- China
- Prior art keywords
- food
- module
- blood glucose
- ins
- information
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medical Treatment And Welfare Office Work (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
The invention discloses an intelligent drug release device which comprises a storage module, an input module, a weight detector, a calculation module and a drug release mechanism. The storage module is used for storing food varieties, food sugar indexes and the ratio of CHO/INS. The input module is used for inputting the food varieties. The weight detector detects the food weight. The calculation module is used for inquiring the corresponding food sugar indexes from the storage module according to the food varieties input by the input module, utilizing the food weight detected by the weight detector and the sugar indexes for calculation to obtain the sugar quantities of the input food, reading the ratio of CHO/INS from the storage module, and dividing the sugar quantities of the food by the ratio of CHO/INS to obtain the INS amount required to be output. The drug release mechanism is used for releasing the INS according to the INS amount calculated by the calculation module. By the utilization of the intelligent drug release device, the accuracy of administration dosage can be improved.
Description
Technical field
The present invention relates to the medical medicine infusion art, relate in particular to a kind of intellectual drug releasing device.
Background technology
At present, drug release device is widely applied in the middle of disease treatment.For example, having occurred that at present a kind of insulin medicament discharges pen, is exactly a kind of drug release device of pen type, wherein mainly comprises: syringe needle, insulin pen-cartridge, drug release mechanism etc.But, current drug release device only can discharge medicine in patient body, as injection, high-pressure injection etc., can't provide with the corresponding dose of the characteristic of discharged medicine and control function, its dose is mainly rule of thumb to be estimated to obtain by user, for the treating diabetes field, the treatment field of type i diabetes especially, existing this drug release device can't provide accurate drug dose, cause patient's glycemic control undesirable, the genesis that has accelerated complication.
Summary of the invention
In view of this, main purpose of the present invention is a kind of intellectual drug releasing device, to improve the degree of accuracy of dosage, thereby controls better patient's blood sugar level.
In order to realize the foregoing invention purpose, main technical schemes of the present invention is:
A kind of intellectual drug releasing device, this device comprises:
Memory module, for the ratio C HO/INS of storage food kind and sugary index and saccharide and insulin;
Input module, for inputting the kind of food;
Weight tester, for detection of the weight of described food;
Computing module, for the food species according to described input module input, from sugary index corresponding to described memory module inquiry, utilize the detected food weight of described weight tester and described sugary Index for Calculation to obtain the sugary quantity of inputted food; Read CHO/INS from described memory module, the sugary quantity of described food, divided by CHO/INS, is obtained to the amount of insulin that will export;
Drug release mechanism, for the amount of insulin uelralante calculated according to described computing unit.
In a kind of preferred implementation, this intellectual drug releasing device further comprises the blood glucose module, for receiving blood glucose information, according to predetermined span, described blood glucose information is carried out to classification, and stores in described memory module.
In a kind of preferred implementation, this intellectual drug releasing device further comprises judge module, added up for the blood glucose information to after stored described classification, when the blood glucose information of specified level reaches predetermined quantity, triggered default respective operations.
In a kind of preferred implementation, described judge module specifically for: when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module reduced to a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module is improved to a default unit value.
In a kind of preferred implementation, described blood glucose information comprises the time; Described judge module is specifically for residing period of time of determining blood glucose information according to default period division information, blood glucose information after classification in day part is added up, when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module is corresponding reduce a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module is corresponding improve a default unit value.
In a kind of preferred implementation, the sugary index information of the food in described memory module is pre-stored; Perhaps, this device further comprises the sugary index input module of food, for receiving the sugary index information of food of user's input, and is stored in described memory module.
In a kind of preferred implementation, further comprise the blood sugar test prompting module, whether arrive the scheduled time for judgement after the insulin input, be to send alarm signal.
In a kind of preferred implementation, described device further comprises Man Machine Interface, for the information to described memory module, modifies.
In a kind of preferred implementation, between described drug release mechanism and described computing module, by wireless signal, communicate.
Compared with prior art, the present invention utilizes memory module storage food kind and sugary index thereof, and the ratio C HO/INS of saccharide and insulin, utilize the kind of input module input food, computing module is inquired about corresponding sugary index according to the food species of described input module input from described memory module, utilize the detected food weight of described weight tester and described sugary Index for Calculation to obtain the sugary quantity of inputted food, read CHO/INS from described memory module, by the sugary quantity of described food divided by CHO/INS, obtain the amount of insulin that will export, finally, the amount of insulin uelralante calculated according to described computing unit by drug release mechanism.Therefore, the food species that the present invention can will take according to the patient and quantity intelligence, accurately calculate the insulin dose of required input, improve the degree of accuracy of dosage, controlled better patient's blood sugar level, slowed down generation and the development of diabetic complication.
The accompanying drawing explanation
A kind of composition schematic diagram that Fig. 1 is intellectual drug releasing device of the present invention;
Another composition schematic diagram that Fig. 2 is intellectual drug releasing device of the present invention;
Another composition schematic diagram that Fig. 3 is intellectual drug releasing device of the present invention;
Another composition schematic diagram that Fig. 4 is intellectual drug releasing device of the present invention.
The specific embodiment
Below by specific embodiments and the drawings, the present invention is described in further details.
A kind of composition schematic diagram that Fig. 1 is intellectual drug releasing device of the present invention; Referring to Fig. 1, this intellectual drug releasing device 100 comprises:
Described CHO/INS is the CHO/INS corresponding with the user, each user's CHO/INS may be different, within the different time periods, same user's CHO/INS is also likely different, therefore the present invention also further comprises Man Machine Interface, modify for the CHO/INS to described memory module 101, can certainly modify to the sugary index of food.
Described input module 102 can provide Man Machine Interface, and as devices such as display screen, keyboards, the user can pass through these Man Machine Interface input messages.
Described weight tester is generally weight sensor, pressure transducer, can detect weight of object, detected weight is converted to the signal of telecommunication and sends to aftermentioned computing module 102.
For example, the sugary index of having stored steamed bread in described memory module 101 is 50%, if input module 102 inputs " steamed bread ", quantity is " 150 gram ", to inquire the sugary index that steamed bread is corresponding from memory module 101 be 50% to computing module 103, and the sugary quantity of current inputted steamed bread is 150 * 50%=75 gram, if user's CHO/INS is 15, needing the amount of insulin of output is 75 ÷ 15=5U, the unit that described U is insulin.
Another composition schematic diagram that Fig. 2 is intellectual drug releasing device of the present invention; Referring to Fig. 2, this intellectual drug releasing device further comprises blood glucose module 106, for receiving blood glucose information, according to predetermined span, described blood glucose information is carried out to classification, and stores in described memory module 101.
In a kind of preferred embodiment, described blood glucose module 106 can comprise for the blood sugar test module of test organism blood glucose value and classification computing module.
Described blood sugar test module is for detection of the blood glucose value of organism, and generation can be carried out the blood glucose level data of communication transfer.Organism of the present invention is human body, can be also animal body, and the human body of take herein describes as example.The concentration value that described blood glucose value is glucose in blood, the sample that described blood sugar test module detects can be blood sample, by the blood glucose sample is detected and draws blood glucose value, the concrete blood sugar test technology adopted can be industry blood sugar test product technology commonly used, such as electrochemical process test and luminous reflectance technical testing etc.; The physiologically sample that perhaps described blood sugar test module also can directly or indirectly reflect blood glucose value by detecting other, and calculate blood glucose value, can be for example to calculate the detector of blood glucose value by detecting body fluid, can be also by skin or eyes are carried out to the detector that spectrum analysis calculating obtains blood glucose value.The blood glucose that described blood sugar test module detects can be that single-point is discrete, can be also dynamically continuous.As for the blood glucose value in concrete how detection of biological body, not emphasis of the present invention, can be with reference to prior art, this paper repeats no more.Described classification computing module is for carrying out classification calculating according to predetermined span by the detected blood glucose value of described blood sugar test module, for example described span can be divided into Three Estate: the hyperglycemia scope, the euglycemia scope, the hypoglycemia scope, described range of blood sugar also can adopt according to the difference of time period different value ranges, for example the hyperglycemia scope of period can be to be greater than 6.2 before the meal, the hyperglycemia scope of period can be to be greater than 8.6 after the meal, and described classification computing module can provide Man Machine Interface, by this Man Machine Interface, described range of blood sugar can be arranged by the user.
In another kind of preferred embodiment, described blood glucose module 106 also can comprise blood glucose input module and classification computing module.
Described blood glucose input module can provide Man Machine Interface or the communication interface with extraneous blood glucose monitoring system is provided, the user can input blood glucose information (comprising blood glucose value, testing time etc.) by hand by described Man Machine Interface, perhaps described and communication interface extraneous blood glucose monitoring system can receive the detected blood glucose information of extraneous blood glucose monitoring system, and this communication interface can be that wired communication interface can be also wireless communication interface.Described classification computing module carries out classification calculating for the blood glucose value described blood glucose input module received according to predetermined span, and concrete classification account form as mentioned above.
As shown in Figure 2, in a kind of preferred embodiment, described intellectual drug releasing device further comprises judge module 107, for the blood glucose information after the described classification to stored, is added up, when the blood glucose information of specified level reaches predetermined quantity, trigger default respective operations.
In a kind of preferred embodiment, described judge module 107 specifically for: when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module 101 reduced to a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module 101 is improved to a default unit value.
For example, reach predetermined quantity (as over three times), display alarm information when other blood glucose information of hyperglycemia scope level, for example show " CHO/INS is too high; suggestion reduces the value of CHO/INS ", or automatically described CHO/INS is reduced to a default unit value, for example reduce by 1.If the blood glucose information of the hypoglycemia access level of this period reaches predetermined quantity (as three times), show " CHO/INS is too low, and suggestion increases the value of CHO/INS ", or automatically described CHO/INS is increased to a default unit value, for example increase by 1.
In a kind of preferred embodiment, described blood glucose information comprises the time; Described judge module 107 is specifically for residing period of time of determining blood glucose information according to default period division information, blood glucose information after classification in day part is added up, when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module 101 is corresponding reduce a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module 101 is corresponding improve a default unit value.
For example, described period division information comprises early, middle and late, four periods of night, and right CHO/INS of each period is likely different.Suppose that early the CHO/INS of period is 15, if the blood glucose information of the hyperglycemia access level of this period reaches predetermined quantity (as three times), show " CHO/INS is too high; suggestion reduces the value of CHO/INS ", or automatically described CHO/INS is reduced to a default unit value, for example reduce by 1, become 14.If the blood glucose information of the hypoglycemia access level of this period reaches predetermined quantity (as three times), show " CHO/INS is too low, and suggestion increases the value of CHO/INS ", or automatically described CHO/INS is increased to a default unit value, for example increase by 1, become 16.
The sugary index information of food in described memory module 101 is pre-stored; Perhaps, as shown in Figure 3, this device further comprises the sugary index input module 108 of food, for receiving the sugary index information of food of user's input, and is stored in described memory module 101.
Referring to Fig. 3, in a kind of preferred embodiment, intellectual drug releasing device of the present invention also further comprises blood sugar test prompting module 109, (this scheduled time can be arranged by the user by Man Machine Interface whether to arrive the scheduled time for judgement after the insulin input, and be stored in memory module 101), be to send alarm signal (the random time reminding user that for example can be arranged in 30 minutes to 4 hours is after the meal surveyed blood glucose).
In a kind of preferred embodiment,, described device can further include Man Machine Interface 111, for the information to described memory module 101, modifies.
In above-described embodiment, between described drug release mechanism 104 and computing module 103, can be wire communication, can be also radio communication.As Fig. 4 is that another of intellectual drug releasing device of the present invention forms schematic diagram, in the present embodiment, between described drug release mechanism 104 and other module, it is Split type structure, described drug release mechanism 104 directly sticks on patient's skin 110, perhaps can be embedded under patient skin, between described drug release mechanism 104 and described computing module 103, by wireless signal, communicate, facilitate persistence to injectable drug in patient body, as this drug release mechanism 104 can be a kind of syringe pump (as insulin infusion pump etc.) that can the sustained release medicine, other module can be integrated in a module 401, with described drug release mechanism 104, separates, and facilitates the user to carry and holds and take, and needn't stick on patient skin or be embedded under patient skin.This separate mode can make the patient after the syringe pump of having worn the sustained release medicine, both can realize the function of intelligence computation drug dose of the present invention and the various embodiments described above, does not affect again patient's freedom of action, facilitates the patient to carry described syringe pump.
In a preferred embodiment of the present invention, described intellectual drug releasing device is that insulin medicament discharges pen.
In another kind of preferred embodiment of the present invention, described intellectual drug releasing device is that insulin medicament discharges pump.
The above; be only the present invention's specific embodiment preferably, but protection scope of the present invention is not limited to this, anyly is familiar with the people of this technology in the disclosed technical scope of the present invention; the variation that can expect easily or replacement, within all should being encompassed in protection scope of the present invention.
Claims (9)
1. an intellectual drug releasing device, is characterized in that, this device comprises:
Memory module, for the ratio C HO/INS of storage food kind and sugary index and saccharide and insulin;
Input module, for inputting the kind of food;
Weight tester, for detection of the weight of described food;
Computing module, for the food species according to described input module input, from sugary index corresponding to described memory module inquiry, utilize the detected food weight of described weight tester and described sugary Index for Calculation to obtain the sugary quantity of inputted food; Read CHO/INS from described memory module, the sugary quantity of described food, divided by CHO/INS, is obtained to the amount of insulin that will export;
Drug release mechanism, for the amount of insulin uelralante calculated according to described computing unit.
2. intellectual drug releasing device according to claim 1, it is characterized in that, this intellectual drug releasing device further comprises the blood glucose module, for receiving blood glucose information, according to predetermined span, described blood glucose information is carried out to classification, and store in described memory module.
3. intellectual drug releasing device according to claim 2, it is characterized in that, this intellectual drug releasing device further comprises judge module, for the blood glucose information to after stored described classification, added up, when the blood glucose information of specified level reaches predetermined quantity, trigger default respective operations.
4. intellectual drug releasing device according to claim 3, it is characterized in that, described judge module specifically for: when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module reduced to a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show corresponding warning information or the CHO/INS in described memory module is improved to a default unit value.
5. intellectual drug releasing device according to claim 4, is characterized in that, described blood glucose information comprises the time;
Described judge module is specifically for residing period of time of determining blood glucose information according to default period division information, blood glucose information after classification in day part is added up, when other blood glucose information of hyperglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module is corresponding reduce a default unit value; When other blood glucose information of hypoglycemia scope level reaches predetermined quantity, show that corresponding warning information or the CHO/INS that this period in memory module is corresponding improve a default unit value.
6. intellectual drug releasing device according to claim 1, is characterized in that,
The sugary index information of food in described memory module is pre-stored;
Perhaps, this device further comprises the sugary index input module of food, for receiving the sugary index information of food of user's input, and is stored in described memory module.
7. intellectual drug releasing device according to claim 1, is characterized in that, further comprises the blood sugar test prompting module, for judgement, after the insulin input, whether arrives the scheduled time, is to send alarm signal.
8. intellectual drug releasing device according to claim 1, is characterized in that, described device further comprises Man Machine Interface, for the information to described memory module, modifies.
9. intellectual drug releasing device according to claim 1, is characterized in that, between described drug release mechanism and described computing module, by wireless signal, communicates.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310483151.2A CN103495232A (en) | 2013-10-16 | 2013-10-16 | Intelligent drug release device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310483151.2A CN103495232A (en) | 2013-10-16 | 2013-10-16 | Intelligent drug release device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103495232A true CN103495232A (en) | 2014-01-08 |
Family
ID=49860545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310483151.2A Pending CN103495232A (en) | 2013-10-16 | 2013-10-16 | Intelligent drug release device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103495232A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107982018A (en) * | 2017-12-04 | 2018-05-04 | 戴玉国 | A kind of diabetes intelligent nursing device |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1449840A (en) * | 2002-02-26 | 2003-10-22 | 生命扫描有限公司 | System and method for remotely medicine infusion and analyte monitoring |
| CN2659453Y (en) * | 2003-11-21 | 2004-12-01 | 王勤 | Splitting insulin pump |
| CN2857962Y (en) * | 2005-05-26 | 2007-01-17 | 胡凤龙 | Intelligent micro-injection device |
| CN101214399A (en) * | 2008-01-11 | 2008-07-09 | 西北工业大学 | Split type insulin pump |
| EP2060284A1 (en) * | 2007-11-13 | 2009-05-20 | F.Hoffmann-La Roche Ag | Medical injection device having data input means and a pivotable display |
| CN101644599A (en) * | 2009-06-22 | 2010-02-10 | 李秀 | Weighing analyzing apparatus and method thereof |
| CN101785701A (en) * | 2009-01-23 | 2010-07-28 | 李秀 | Device and method for processing information, equipment and reagent carrier |
| CN102000372A (en) * | 2010-12-09 | 2011-04-06 | 江苏华阳电器有限公司 | Intelligent insulin pump system |
| CN102802522A (en) * | 2010-02-25 | 2012-11-28 | 生命扫描苏格兰有限公司 | Analyte testing method and system with safety warnings for insulin dosing |
| CN102836481A (en) * | 2012-09-29 | 2012-12-26 | 哈尔滨工业大学 | Novel insulin pump |
| CN203577053U (en) * | 2013-10-16 | 2014-05-07 | 理康互联科技(北京)有限公司 | Intelligent medicine releasing device |
-
2013
- 2013-10-16 CN CN201310483151.2A patent/CN103495232A/en active Pending
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1449840A (en) * | 2002-02-26 | 2003-10-22 | 生命扫描有限公司 | System and method for remotely medicine infusion and analyte monitoring |
| CN2659453Y (en) * | 2003-11-21 | 2004-12-01 | 王勤 | Splitting insulin pump |
| CN2857962Y (en) * | 2005-05-26 | 2007-01-17 | 胡凤龙 | Intelligent micro-injection device |
| EP2060284A1 (en) * | 2007-11-13 | 2009-05-20 | F.Hoffmann-La Roche Ag | Medical injection device having data input means and a pivotable display |
| CN101214399A (en) * | 2008-01-11 | 2008-07-09 | 西北工业大学 | Split type insulin pump |
| CN101785701A (en) * | 2009-01-23 | 2010-07-28 | 李秀 | Device and method for processing information, equipment and reagent carrier |
| CN101644599A (en) * | 2009-06-22 | 2010-02-10 | 李秀 | Weighing analyzing apparatus and method thereof |
| CN102802522A (en) * | 2010-02-25 | 2012-11-28 | 生命扫描苏格兰有限公司 | Analyte testing method and system with safety warnings for insulin dosing |
| CN102000372A (en) * | 2010-12-09 | 2011-04-06 | 江苏华阳电器有限公司 | Intelligent insulin pump system |
| CN102836481A (en) * | 2012-09-29 | 2012-12-26 | 哈尔滨工业大学 | Novel insulin pump |
| CN203577053U (en) * | 2013-10-16 | 2014-05-07 | 理康互联科技(北京)有限公司 | Intelligent medicine releasing device |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107982018A (en) * | 2017-12-04 | 2018-05-04 | 戴玉国 | A kind of diabetes intelligent nursing device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6929673B2 (en) | Calculator, liquid dispenser, and insulin administration system | |
| US11224362B2 (en) | Method and/or system for determining blood glucose reference sample times | |
| EP3164170B1 (en) | Glucagon administration system and methods | |
| CN103443798B (en) | System for optimizing a patient's drug dosage regimen over time | |
| US10293109B2 (en) | Adaptive system for optimizing a drug dosage regimen over time | |
| US20110184343A1 (en) | Drug delivery with event notification | |
| US8439897B2 (en) | Assessing residual insulin time | |
| US20140074059A1 (en) | Method and system to indicate glycemic impacts of insulin infusion pump commands | |
| US20170213009A1 (en) | Titration of basal insulin with two modes | |
| WO2013186104A1 (en) | Medical device and method for displaying medical data by a medical device | |
| CN104027867A (en) | Portable intelligent dual-function diabetes treatment pump | |
| US20230233112A1 (en) | Optimizing medication dosage based on analyte sensor data | |
| CN102048522B (en) | Monitoring prompt device and method and corresponding device | |
| CN103495231A (en) | Intelligent drug release device | |
| CN203577053U (en) | Intelligent medicine releasing device | |
| CN103495232A (en) | Intelligent drug release device | |
| US20220168505A1 (en) | Device and methods for a simple meal announcement for automatic drug delivery system | |
| KR20190102711A (en) | insulin-pen attachable blood glucose management device and blood glucose management IoT platform | |
| US11684716B2 (en) | Techniques to reduce risk of occlusions in drug delivery systems | |
| US20220096749A1 (en) | Drug delivery device with integrated optical-based glucose monitor | |
| US20230248909A1 (en) | Techniques for determining medication correction factors in automatic medication delivery systems | |
| CN203577072U (en) | Medicine releasing device | |
| EP4261835A1 (en) | System and method for creating or adjusting manual basal profiles | |
| US20240000347A1 (en) | System and method for evaluating risk of hypoglycemia or hyperglycemia | |
| WO2024081559A1 (en) | System and method for determining the effect of ingestion of meals of varying carbohydrate content |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140108 |